We are live on ! Find out more
AUXL

AUXILIUM PHARAMCEUTICALS INC
AUXL

Delisted

AUXL was delisted on the 29th of January, 2015.

Back to rankings

147 hedge funds and large institutions have $1.11B invested in AUXILIUM PHARAMCEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 61 increasing their positions, 49 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,948% more call options, than puts

Call options by funds: $191M | Put options by funds: $9.33M

24% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 49

12% more capital invested

Capital invested by funds: $987M → $1.11B (+$120M)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

2% less funds holding

Funds holding: 150 → 147 (-3)

12% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 25

Holders
147
Holders Change
-3
Holders Change %
-2%
% of All Funds
4.27%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
22
Increased
61
Reduced
49
Closed
25
Calls
$191M
Puts
$9.33M
Net Calls
+$182M
Net Calls Change
+$49.4M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$30.6M
2
TCP
TAMRO Capital Partners
Virginia
+$17.9M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.7M
4
TCM
Tamarack Capital Management
California
+$13.7M
5
PHS
PFM Health Sciences
California
+$11.9M

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$21.4M
2
Citadel Advisors
Citadel Advisors
Florida
-$20.6M
3
SCA
SAC Capital Advisors
Connecticut
-$13.4M
4
Invesco
Invesco
Georgia
-$11M
5
MHP
Manatuck Hill Partners
Connecticut
-$10.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
FM
51
Forward Management
California
$2.85M +$912K +48,380 +44%
BIM
52
BlackRock Investment Management
Delaware
$2.81M -$59.3K -3,148 -2%
RCAMU
53
Rothschild & Co Asset Management US
Connecticut
$2.7M -$40.2K -2,130 -2%
Charles Schwab
54
Charles Schwab
California
$2.64M +$85K +4,507 +4%
NI
55
Numeric Investors
Massachusetts
$2.63M -$3.04M -161,100 -56%
TAM
56
Tocqueville Asset Management
New York
$2.45M +$302K +16,000 +16%
Renaissance Technologies
57
Renaissance Technologies
New York
$2.4M -$2.31M -122,600 -51%
WFM
58
Wilmington Funds Management
Delaware
$2.31M +$12.4K +660 +0.6%
T. Rowe Price Associates
59
T. Rowe Price Associates
Maryland
$2.18M +$300K +15,900 +18%
PA
60
Perceptive Advisors
New York
$2.07M +$1.89M +100,000 New
RSCM
61
Rock Springs Capital Management
Maryland
$2.07M +$1.89M +100,000 New
KCM
62
Kingdon Capital Management
New York
$2.07M +$1.89M +100,000 New
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
$1.85M +$11.3K +600 +0.7%
RPAM
64
Rhenman & Partners Asset Management
Sweden
$1.76M +$1.6M +85,000 New
ECP
65
Elk Creek Partners
Colorado
$1.74M +$1.59M +84,090 New
MAA
66
Managed Account Advisors
New Jersey
$1.74M +$300K +15,915 +23%
AI
67
Analytic Investors
California
$1.71M +$1.25M +66,564 +418%
GI
68
GLG Inc
New York
$1.62M – – –
Massachusetts Financial Services
69
Massachusetts Financial Services
Massachusetts
$1.61M -$110K -5,810 -7%
Nomura Holdings
70
Nomura Holdings
Japan
$1.6M +$195K +10,369 +15%
LCS
71
Levin Capital Strategies
New York
$1.6M +$1.46M +77,218 New
Two Sigma Investments
72
Two Sigma Investments
New York
$1.59M +$1.44M +76,629 New
GCP
73
GSA Capital Partners
United Kingdom
$1.46M +$194K +10,267 +17%
ACM
74
Argent Capital Management
Missouri
$1.39M -$2.31M -122,750 -65%
ACPU
75
Arrowgrass Capital Partners (US)
Delaware
$1.35M +$1.23M +65,000 New
1 2
3
4 5

AUXL Hedge Fund Activity: Q4 2013 in Review

147 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q4 2013, worth a combined $1.11B — up 12% from $987M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of AUXL and 22 opened new positions — a net loss of 3 holders — while 49 trimmed existing stakes and 61 added.

The largest buyer was Deerfield Management, adding an estimated $30.6M. The largest seller was Artal Group, cutting an estimated $21.4M.

  • 147 institutional investors held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q4 2013, down from 150 in Q3 2013.
  • Funds reported $1.11B of AUXILIUM PHARAMCEUTICALS INC stock for Q4 2013, up 12% quarter-over-quarter.
  • 22 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q4 2013 and 25 closed out, a net change of -3 holders.
  • The largest AUXILIUM PHARAMCEUTICALS INC buyer in Q4 2013 was Deerfield Management, an estimated $30.6M added.
  • The largest AUXILIUM PHARAMCEUTICALS INC seller in Q4 2013 was Artal Group, an estimated $21.4M sold.

Based on aggregated 13F filings for Q4 2013.